Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Activity Monitoring Assessment of Opiate Withdrawal - 4

This study has been completed.
Washington DC VA
Information provided by:
National Institute on Drug Abuse (NIDA) Identifier:
First received: September 20, 1999
Last updated: March 20, 2013
Last verified: December 2002

The purpose of this study is to determine if hyperactivity accompanies abrupt opiate withdrawal in heroin addicts, to determine if computerized solid state activity monitors are capable of quantifying hyperactivity, and to quantify the physical and affective symptoms occurring during abrupt withdrawal in heroin addicts and morphine's capacity to alleviate these symptoms.

Condition Intervention Phase
Opioid-Related Disorders
Drug: Morphine
Phase 2

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Activity Monitoring Assessment of Opiate Withdrawal

Resource links provided by NLM:

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Depression
  • Anxiety
  • Withdrawal severity
  • Activity
  • Opiate secondary withdrawal

Estimated Enrollment: 0

Ages Eligible for Study:   21 Years to 55 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No

Please contact site for information.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00000335

United States, District of Columbia
Washington DC VA
Washington, District of Columbia, United States, 20422
Sponsors and Collaborators
Washington DC VA
Principal Investigator: Steven Deutsch, M.D. Washington DC VA
  More Information

No publications provided Identifier: NCT00000335     History of Changes
Other Study ID Numbers: NIDA-3-0009-4, Y01-3-0009-4
Study First Received: September 20, 1999
Last Updated: March 20, 2013
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Opioid-Related Disorders
Chemically-Induced Disorders
Mental Disorders
Substance-Related Disorders processed this record on November 23, 2014